Strides Pharma gets USFDA nod for antidepressant medication
As per IMS, Fluoxetine tablets have a market size of USD 23.9 million. This approval further strengthens the company's presence in the Fluoxetine portfolio, complementing the existing approval of Fluoxetine capsules, which has a market size of USD106 million, the Bengaluru based firm said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 9, 2024 Category: Pharmaceuticals Source Type: news
The Menstrual Mood Disorder You ’ve Never Heard About
Ever since she was a teenager, Tanya knew her mood swings were a problem. She had periodic bouts of anger and depression that left her wanting to die. Her life was a roller coaster of highs and lows but doctors couldn’t figure out what was wrong. Five years ago, she decided she’d had enough. She wanted to end her life.
Tanya managed to talk herself out of it and instead did some googling. She stumbled across a website about premenstrual dysphoric disorder (PMDD), a menstrual mood disorder, that impacts roughly 3 to 8% of menstruators. PMDD means having severe and debilitating mood swings right around one&rsq...
Source: TIME: Health - April 4, 2024 Category: Consumer Health News Authors: Shalene Gupta Tags: Uncategorized freelance Source Type: news
Pressure grows to ditch controversial forced swim test in rodent studies of depression
For the past few decades, scientists studying candidate antidepressant drugs have had a convenient animal test: how long a rodent dropped in water keeps swimming.
Invented in 1977
, the forced swim test (FST) hinged on the idea that a depressed animal would give up quickly. It seemed to work: Antidepressants and electroconvulsive therapy often made the animal try harder. The test remains popular,
appearing in about 600 papers per year
.
But researchers have recently begun to question the assumption that the test really gauges depression and is a good predictor of human responses to drugs. Oppositi...
Source: ScienceNOW - March 20, 2024 Category: Science Source Type: news
Taking Prozac During Pregnancy Can Affect Fetal Brain Development: Study
From New York Post: “Taking antidepressants such as Prozac during pregnancy can affect the child’s brain development and potentially lead to them having mental health disorders later in life, a new study warns. The research, published Friday in the journal Nature Communications, is said to be the…#naturecommunications #wonchanoh (Source: Reuters: Health)
Source: Reuters: Health - March 11, 2024 Category: Consumer Health News Source Type: news
' Twin Peaks on Prozac': A Cookie Cutter Cabin Gets a One-of-a-Kind Makeover
An interior design scheme that’s both moody and playful turns traditional mountain-house decor on its head. (Source: Reuters: Health)
Source: Reuters: Health - February 28, 2024 Category: Consumer Health News Source Type: news
What are Some Causes of Acute Onset of Loss of Speech Abilities?
Discussion
Acute mental status changes are worrisome in the least and scary at their worst. Seizures, cerebrovascular problems and central nervous system tumor swirl in professionals’ heads as they take in the history, physical examination and start to evaluate and manage the problem. Usually respiratory distress is recognized by family members and treatment is also sought.
Another cause of loss of speech is selective (or elective) mutism (SM). The child does not speak at all or minimally. When speaking it is usually within a close group of individuals or in certain circumstances such as only speaking to a parent o...
Source: PediatricEducation.org - February 19, 2024 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
Antidepressants taken by 400,000 US pregnant women each year can damage a baby's brain in the womb and increase their risk of mental health problems in the future, study suggests
Prozac, also known as fluoxetine, increases levels of mood-boosting serotonin in the brain - but scientists discovered this can affect a child's developing prefrontal cortex. (Source: the Mail online | Health)
Source: the Mail online | Health - February 16, 2024 Category: Consumer Health News Source Type: news
Psychedelic drugs: Follow the money
The golden road to pharmaceutical riches can quickly become a rocky wilderness trail. Chemical compounds that hit a target in the lab often fall short in human studies. But biotech startups, academic scientists and investors say that research into psychedelic drugs starts with a major advantage:…#chemical #mdma #borisheifets #prozac #venture #empathventures #tabularasaventures #newyorkcity #psymedventures #fda (Source: Reuters: Health)
Source: Reuters: Health - December 12, 2023 Category: Consumer Health News Source Type: news
Sexual Dysfunction After Stopping SSRI Antidepressants
Some patients are speaking up about lasting sexual problems after stopping antidepressants, a poorly understood condition. (Source: NYT Health)
Source: NYT Health - November 9, 2023 Category: Consumer Health News Authors: Azeen Ghorayshi Tags: Research Antidepressants Depression (Mental) Sex Serotonin (Chemical) Prozac (Drug) Drugs (Pharmaceuticals) audio-neutral-informative Source Type: news
Long COVID Research Is In Its ‘ Most Hopeful ’ Phase Yet
A phenomenal amount of research on Long COVID—the name for chronic symptoms following a case of COVID-19—has been published over the past three years. But scientific advances have yet to bring relief to people who are already sick, a group estimated to include about 5% of U.S. adults but hard to precisely quantify due to the difficulty of diagnosing people correctly.
Researchers are optimistic that breakthroughs are coming. The U.S. National Institutes of Health (NIH) has launched multiple clinical trials focused on potential therapies, and several recent studies have pointed to biomarkers that may help doct...
Source: TIME: Health - October 23, 2023 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
Low serotonin levels might explain some Long Covid symptoms, study proposes
Although theories abound, there is still no clear explanation for how infection with SARS-CoV-2 leads to lingering difficulty concentrating, problems with attention and memory, and other, often-debilitating symptoms associated with Long Covid.
Now, researchers studying people who reported these and other symptoms months postinfection propose a new possibility: That
inflammation in response to SARS-CoV-2 causes a drop in serotonin
—a chemical messenger involved in regulating mood and digestion, among myriad other functions—which in turn causes cognitive problems.
The propos...
Source: ScienceNOW - October 16, 2023 Category: Science Source Type: news
Microdosing Unveiled: Expert's Take On The Practice's Ups & Downs
Paul Austin, the trainer of psychedelics microdosing practitioners, spoke to Benzinga about his collaboration with Lauren Mugglebee, who transitioned from a career at Meta META to coaching high-end tech and corporate clients in Silicon Valley. Austin is focused on passing on knowledge and…#paulaustin #laurenmugglebee #metameta #siliconvalley #prozac #lexapro #austin #pixabay #pexels (Source: Reuters: Health)
Source: Reuters: Health - September 24, 2023 Category: Consumer Health News Source Type: news
Fluoxetine restrains allergic inflammation by targeting an Fc ɛRI-ATP positive feedback loop in mast cells | Science Signaling
Fluoxetine inhibits IgE- and ATP-driven driven mast cell function in allergic inflammation. (Source: Signal Transduction Knowledge Environment)
Source: Signal Transduction Knowledge Environment - September 12, 2023 Category: Science Source Type: news
Hot weight loss drugs tested as addiction treatments
When the diabetes treatments known as GLP-1 analogs reached the market in 2005, doctors advised patients taking the drugs that they might lose a small amount of weight. Talk about an understatement. Obese people can drop more than 15% of their body weight, studies have found, and two of the medications are now approved by the U.S. Food and Drug Administration (FDA) for weight reduction. A surge in demand for the drugs as slimming treatments has led to shortages. “This class of drugs is exploding in popularity,” says clinical psychologist Joseph Schacht of the University of Colorado School of Medicine.
But patient...
Source: ScienceNOW - August 28, 2023 Category: Science Source Type: news
Hot weight loss drugs tested as addiction treatments
When the diabetes treatments known as GLP-1 analogs reached the market in 2005, doctors advised patients taking the drugs that they might lose a small amount of weight. Talk about an understatement. Obese people can drop more than 15% of their body weight, studies have found, and two of the medications are now approved by the U.S. Food and Drug Administration (FDA) for weight reduction. A surge in demand for the drugs as slimming treatments has led to shortages. “This class of drugs is exploding in popularity,” says clinical psychologist Joseph Schacht of the University of Colorado School of Medicine.
But patient...
Source: ScienceNOW - August 28, 2023 Category: Science Source Type: news
